91九色视频

header-logo
91九色视频 Find a Doctor
headshot

Ahmed Zayed Obeidat, MD, PhD

Associate Professor

Location

  • Neuroscience Center 鈥� Specialty Clinics
  • 900 N. 92nd St.
  • Milwaukee, WI 53226

Specialties

  • Neurology

New & Established Patients Call

The key to success is teamwork. We will work together with you and your loved ones to fight MS and other neuroimmunological diseases in a personalized and comprehensive approach to best fit your needs and expectations. Remember, you are the center of our care and persistence is the key to success!

Overview

Diseases and Conditions

  • Multiple Sclerosis (MS)
  • Stiff Person Syndrome (SPS)
  • Neuromyelitis Optica (NMO)
  • Autoimmune Diseases of the Central Nervous System
  • Autoimmune Encephalitis
  • Neurosarcoidosis
  • Anti-MOG Disease

Treatments and Services

  • Neuro-Immunology
  • Oral/injectable/infused and Symptomatic Therapies for Multiple Sclerosis
  • Virtual Visit

Patients Ages Seen

  • Adult
  • Senior

Languages

  • English
  • Arabic

Hospital Affiliations

  • Froedtert Hospital – Milwaukee

Board Certifications

  • Neurology

Clinic Locations

map of clinics' locations

Biography

Dr. Obeidat works with adults in diagnosing, treating and managing Multiple Sclerosis and Immune Disorders of the Central Nervous System.  He received his medical degree with honors from the Jordan University of Science and Technology in 2008. He then joined the graduate program in neuroscience and physiology at Wright State University (WSU) in Dayton, Ohio where he received a PhD in Neuroscience and Physiology in 2013. He completed his neurology residency at the University of Cincinnati in 2017 as well as fellowship training in Demyelinating Diseases and Neuroimmunology, also from the University of Cincinnati, in 2018. Dr. Obeidat is an advocate for medical humanities and believes in the power of patient stories in shaping a successful, and a long-lasting patient-doctor relationship. In his free time, he enjoys reading and writing personal reflections and narrative medicine in its various forms.

Education and Training

Doctor of Philosophy in Biomedical Sciences (Neuroscience and Physiology) - Wright State University - Dayton, OH (2013)
Fellowship in Neuroimmunology and Multiple Sclerosis - University of Cincinnati - Cincinnati, OH (2017-2018)
Residency in Neurology - University of Cincinnati - Cincinnati, OH (2014-2017)

Publications

  • (Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN.) J Neuroimmunol. 2025 Feb 15;399:578519 PMID: 39731832 SCOPUS ID: 2-s2.0-85213253349 12/29/2024

  • (Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN.) J Neuroimmunol. 2025 Feb 15;399:578502 PMID: 39643951 SCOPUS ID: 2-s2.0-85211034715 12/07/2024

  • (Nerenz RD, Hooshmand SI, Jackowiak E, Shirilla D, Yang Y, Yang K, Obeidat AZ.) Am J Clin Pathol. 2025 Jan 28;163(1):109-120 PMID: 39255415 SCOPUS ID: 2-s2.0-85217064358 09/10/2024

  • (Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D, evolutionRMS investigators.) Lancet Neurol. 2024 Nov;23(11):1119-1132 PMID: 39307151 09/23/2024

  • (Obeidat AZ.) Mult Scler. 2024 Nov;30(13):1698 PMID: 39240139 SCOPUS ID: 2-s2.0-85203433093 09/06/2024

  • (Porwal MH, Razzak AN, Kumar V, Obeidat AZ, Sharma U.) Epilepsy Res. 2024 Jul;203:107382 PMID: 38761467 SCOPUS ID: 2-s2.0-85193210316 05/19/2024

  • (Hjerthen IG, Trápaga Hacker C, Meador W, Obeidat AZ, Horta L, Mateen FJ.) Ann Clin Transl Neurol. 2024 Apr;11(4):1011-1020 PMID: 38374778 PMCID: PMC11021617 SCOPUS ID: 2-s2.0-85186173891 02/20/2024

  • (Razzak AN, Hernandez RS, Salter A, Obeidat AZ.) Mult Scler Relat Disord. 2024 Mar;83:105438 PMID: 38242052 SCOPUS ID: 2-s2.0-85183017643 01/20/2024

  • (Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G, Frexalimab Phase 2 Trial Group.) N Engl J Med. 2024 Feb 15;390(7):589-600 PMID: 38354138 02/14/2024

  • (Abboud H, Subei A, Sengul B, Shin RK, Goulette P, Walch R, Coté J, Pace R, Obeidat AZ, Ferayorni L, Gholizadeh S.) Front Immunol. 2024;15:1526563 PMID: 39867894 PMCID: PMC11757099 SCOPUS ID: 2-s2.0-85215693085 01/27/2025

  • (Abboud H, Subei A, Sengul B, Shin RK, Goulette P, Walch R, Coté J, Pace R, Obeidat AZ, Ferayorni L, Gholizadeh S.) Frontiers in Immunology. 2024;15 SCOPUS ID: 2-s2.0-85215693085 01/01/2024

  • (Hamna Khan, Michelle Maynard, Ahmed Z Obeidat.) Neuroimmunology Reports. Khan, Hamna, Michelle Maynard, and Ahmed Z. Obeidat. Cardiac events in the setting of ofatumumab treatment: An association or A Co-incidence?. Neuroimmunology Reports 6 (2024): 100228. 12/01/2024

Publications of from the

© 2025 91九色视频.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 91九色视频 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.